Ethnic disparities in mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-based cohort study.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
May 2022
Historique:
received: 06 09 2021
accepted: 23 12 2021
pubmed: 14 1 2022
medline: 13 4 2022
entrez: 13 1 2022
Statut: ppublish

Résumé

Ethnic variation in risk of type 2 diabetes is well established, but its impact on mortality is less well understood. This study investigated the risk of all-cause and cardiovascular mortality associated with newly diagnosed type 2 diabetes in White, Asian and Black adults who were overweight or obese. This population-based cohort study used primary care records from the UK Clinical Practice Research Datalink, linked with secondary care and death registry records. A total of 193,528 obese or overweight adults (BMI of 25 or greater), with ethnicity records and no pre-existing type 2 diabetes were identified between 01 January 1995 and 20 April 2018. Multivariable Cox proportional hazards regression estimated hazards ratios (HR) for incident type 2 diabetes in different ethnic groups. Adjusted hazards ratios for all-cause and cardiovascular mortality were determined in individuals with newly diagnosed type 2 diabetes. During follow-up (median 9.8 years), the overall incidence rate of type 2 diabetes (per 1,000 person-years) was 20.10 (95% CI 19.90-20.30). Compared to Whites, type 2 diabetes risk was 2.2-fold higher in Asians (HR 2.19 (2.07-2.32)) and 30% higher in Blacks (HR 1.34 (1.23-1.46)). In individuals with newly diagnosed type 2 diabetes, the rates (per 1,000 person-years) of all-cause mortality and cardiovascular mortality were 24.34 (23.73-24.92) and 4.78 (4.51-5.06), respectively. Adjusted hazards ratios for mortality were significantly lower in Asians (HR 0.70 (0.55-0.90)) and Blacks (HR 0.71 (0.51-0.98)) compared to Whites, and these differences in mortality risk were not explained by differences in severity of hyperglycaemia. Type 2 diabetes risk in overweight and obese adults is greater in Asian and Black compared to White ethnic populations, but mortality is significantly higher in the latter. Greater attention to optimising screening, disease and risk management appropriate to all communities with type 2 diabetes is needed.

Identifiants

pubmed: 35025081
doi: 10.1007/s40618-021-01736-9
pii: 10.1007/s40618-021-01736-9
pmc: PMC8995280
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1011-1020

Informations de copyright

© 2022. The Author(s).

Références

Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Diabetes Care. 2017 Mar;40(3):338-345
pubmed: 27998911
PLoS One. 2019 Apr 12;14(4):e0215362
pubmed: 30978254
BMC Public Health. 2021 Apr 15;21(1):576
pubmed: 33853578
PLoS Genet. 2012 May;8(5):e1002741
pubmed: 22693455
N Engl J Med. 1999 Oct 7;341(15):1097-105
pubmed: 10511607
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Diabet Med. 1992 Jun;9(5):428-31
pubmed: 1611829
Diabet Med. 2015 Feb;32(2):226-34
pubmed: 25186015
Diabetes Care. 2013 Aug;36(8):2366-71
pubmed: 23435157
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Biomark Insights. 2016 Jul 03;11:95-104
pubmed: 27398023
Am J Epidemiol. 1993 Apr 1;137(7):706-18
pubmed: 8484362
Public Health Nutr. 2009 Apr;12(4):497-506
pubmed: 18547457
BMJ. 2008 Jun 28;336(7659):1475-82
pubmed: 18573856
Diabetes Care. 2006 Jul;29(7):1585-90
pubmed: 16801583
Diabetes Care. 2011 Jan;34(1):96-101
pubmed: 20978094
J Am Heart Assoc. 2014 May 08;3(3):e000828
pubmed: 24811615
BMJ Open Diabetes Res Care. 2016 Jun 23;4(1):e000185
pubmed: 27403323
Obesity (Silver Spring). 2012 Oct;20(10):2107-12
pubmed: 22314622
Curr Diab Rep. 2017 Sep 18;17(10):100
pubmed: 28920146
J Epidemiol Community Health. 1996 Apr;50(2):137-9
pubmed: 8762376
Clin Epidemiol. 2017 Mar 15;9:157-166
pubmed: 28352203
Postgrad Med J. 2005 Aug;81(958):486-90
pubmed: 16085737
Diabetes Care. 2013 Sep;36(9):2670-6
pubmed: 23637350
J Environ Public Health. 2016;2016:7014857
pubmed: 26925112

Auteurs

B Iyen (B)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK. barbara.iyen@nottingham.ac.uk.

Y Vinogradova (Y)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK.

R K Akyea (RK)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK.

S Weng (S)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK.

N Qureshi (N)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK.

J Kai (J)

Primary Care Stratified Medicine, Population Health and Lifespan Sciences, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH